Financhill
Buy
66

MAR Quote, Financials, Valuation and Earnings

Last price:
$262.03
Seasonality move :
-1.6%
Day range:
$260.16 - $265.57
52-week range:
$204.55 - $307.52
Dividend yield:
0.97%
P/E ratio:
30.11x
P/S ratio:
2.94x
P/B ratio:
--
Volume:
1.4M
Avg. volume:
1.7M
1-year change:
15.77%
Market cap:
$72.4B
Revenue:
$25.1B
EPS (TTM):
$8.78

MAR Analysts' Consensus Rating

The 25 analysts providing 12-month price projections for Marriott International shares anticipate an average target of $273.29, ranging from a low estimate of $205.00 to a high estimate of $320.00. This average target implies a growth of 3.36% compared to the current stock price of $264.40.

Consensus Price Target

$273.29

Highest Price Target

$320.00

Lowest Price Target

$205.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 6 7 8

Hold 16 17 16

Sell 1 1 1
Consensus Hold Hold Hold

MAR Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is It Time to Sell MercadoLibre?
Is It Time to Sell MercadoLibre?

MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…

Is Tesla Stock High Risk or High Reward?
Is Tesla Stock High Risk or High Reward?

EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…

Why Did Chase Coleman Buy TSM?
Why Did Chase Coleman Buy TSM?

Billionaire Chase Coleman of Tiger Global Management has built a…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 48x

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
55
CTRN alert for Jun 4

Citi Trends [CTRN] is up 2.77% over the past day.

Sell
44
RGC alert for Jun 4

Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.

Buy
63
MLTX alert for Jun 4

MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock